Pamidronate “zebra lines”: A treatment timeline

Osteogenesis imperfecta is a hereditary bone dysplasia characterized by bone fragility, deformity, and short stature. Treatment focuses on preventing bone fractures and symptom relief. Pamidronate, a second-generation bisphosphonate drug that minimizes bone loss, is the chosen treatment in osteogene...

Descripción completa

Detalles Bibliográficos
Autores principales: Loizidou, Avgi, Andronikou, Savvas, Burren, Christine P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2017
Materias:
Pediatric
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5823313/
https://www.ncbi.nlm.nih.gov/pubmed/29484085
http://dx.doi.org/10.1016/j.radcr.2017.07.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5823313/
https://www.ncbi.nlm.nih.gov/pubmed/29484085
http://dx.doi.org/10.1016/j.radcr.2017.07.003

Ejemplares similares